SecBot SecBot

ATRC

AtriCure, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001323885 Healthcare & Medical Devices
$55.31 −1.53 (−2.69%)
Nov 16 4:00 PM ET · prev $56.84
Market cap
$2.9B
Mid cap
Consensus
Buy
73% Buy or better · 15 analysts
Median target
$68.00
+23% · range $50.00–70.00
1 year
+67.0%
from $33.12 · Nov 17
30 days
−0.4%
from $55.53
52-week range
$25.86–65.53
−16% from high · low Jun 2
Avg volume 20D
788.0K
shares / day
Short interest
4.89M
≈9.6% of shares · +0.1%
Days to cover
7.6
at average volume
Insider net
−$4.4M
0 buyers · 9 sellers · since Mar 1
New fund stakes
3
Q3 2026 13F · 2 exits
Filing reports
19
analyzed by SecBot
SecBot read BULLISH 10 reports · 90 days
Balance 0 bearish · 2 bullish · 1 mixed · 7 neutral oldest → newest, height = score
Avg score ·High conf. 7/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    9 insiders sold $4.4M.

  • InstitutionsMIXED

    Q3 2026: 28 added (3 new), 22 trimmed or exited. Largest new: Loomis Sayles & L P $17.6M, Public Sector Pension Investment Board $14.8M.

  • AnalystsBULLISH

    11 of 15 rate it Buy or better. Median target $68.00 (+23%).

  • EstimatesFALLING

    Current-quarter EPS estimate $0.088 → $0.068 over 90 days. 3 up, 3 down in 30 days.

  • Short sellersSTEADY

    Short interest +0.1% to 4.89M shares. 7.6 days to cover, ≈9.6% of shares.

  • TrendRANGE

    4% below its 50-day average.

Who's buying

13F· Q3 2026
3
new positions
2
exits
$32.5M
in new stakes · top 2 shown
FundMoveSharesValue
BlackRock, Inc.ADD7,943,332$446.4M
STATE STREET CORPADD2,128,807$119.6M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPTRIM939,607$52.8M
PRINCIPAL FINANCIAL GROUP INCDOUBLED386,234$21.7M
RENAISSANCE TECHNOLOGIES LLCADD321,000$18.0M
LOOMIS SAYLES & CO L PNEW313,506$17.6M
PUBLIC SECTOR PENSION INVESTMENT BOARDNEW259,000$14.8M
Invesco Ltd.DOUBLED257,288$14.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 73% rate it Buy or better
Strong Buy4Buy7Hold4Sell0Strong Sell0
12-month targets · 9 analysts

Price is inside the target range. Median implies +23%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 4, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Nov 4, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Nov 4, 2026Piper Sandler
REITERATE
REITERATEOverweight
Nov 4, 2026Needham
MAINTAIN
MAINTAINBuy
Nov 4, 2026BTIG
MAINTAIN
MAINTAINBuy
Oct 21, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform

Washington

Corporate Lobbying

10 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$4.4M
sold · 9 insiders
DateInsiderTypeValue
Nov 6, 2026
JOHNSON B KRISTINE
Director
Nov 6, 2026
SELL$143.4K
Nov 4, 2026
Privitera Salvatore
Chief Technical Officer
Nov 4, 2026
SELL$546.3K
Sep 23, 2026
Privitera Salvatore
Chief Technical Officer
Sep 23, 2026
SELL$271.1K
Sep 11, 2026
GROVES REGINA E
Director
Sep 11, 2026
SELL$288.1K
Sep 8, 2026
Privitera Salvatore
Chief Technical Officer
Sep 8, 2026
SELL$201.1K
Sep 2, 2026
Privitera Salvatore
Chief Technical Officer
Sep 2, 2026
SELL$407.6K
Aug 24, 2026
Dahlquist Karl S.
Chief Legal Officer
Aug 24, 2026
SELL$458.1K
Aug 5, 2026
Prange Karen
Director
Aug 5, 2026
SELL$138.3K

Earnings setup

Estimates
$0.07
EPS estimate, this quarter
−22%
estimate change, 90 days
3↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.07$0.04–$0.10-22.1%$159.5M
Next Q$0.03-$0.05–$0.11+1051.1%$158.6M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
ATRC trades disclosed by members of Congress, with disclosure delay.
1 members · 2 buys / 1 sells
DateMemberType AmountDisclosed
Sep 29, 2026 Gilbert CisnerosDHouse AtriCure Inc SELL $1K–$15K Oct 12, 2026 +13d
Aug 20, 2026 Gilbert CisnerosDHouse AtriCure Inc BUY $1K–$15K Sep 10, 2026 +21d
Mar 3, 2026 Gilbert CisnerosDHouse AtriCure Inc BUY $1K–$15K Apr 7, 2026 +35d

Short side

FINRA· Oct 30, 2026
4,889,793
shares short
+0.1%
vs prior settlement
7.6
days to cover
≈9.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 10, 2026 SEC
Two AtriCure insiders sold a combined $690K in open-market sales within a week of the company's strong Q3 earnings…
CLUSTER · Impact 2/10
Nov 6, 2026 Insider
JOHNSON B KRISTINE sold 2,452 shares
Director @ $58.48 ($143.4K)
Nov 4, 2026 Insider
Privitera Salvatore sold 8,404 shares
Chief Technical Officer @ $65.00 ($546.3K)
Nov 3, 2026 Earnings result
ATRC Q3 2026 Earnings: EPS $0.17 (+426.3% vs est)
Sep 30, 2026 Inst.
BlackRock, Inc. · ADD
7,943,332 shares ($446.4M)
Sep 30, 2026 Inst.
STATE STREET CORP · ADD
2,128,807 shares ($119.6M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

19 filings · 4 bullish · 1 bearish · 2 mixed · 12 neutral
All ATRC filing & press-release reports (19)